1,025
Views
90
CrossRef citations to date
0
Altmetric
Critical Care

Opioid intoxications involving butyrfentanyl, 4-fluorobutyrfentanyl, and fentanyl from the Swedish STRIDA project

, , &
Pages 609-617 | Received 08 Apr 2015, Accepted 15 May 2015, Published online: 17 Jun 2015

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (13)

Carlos A. Valdez. (2022) Gas Chromatography-Mass Spectrometry Analysis of Synthetic Opioids Belonging to the Fentanyl Class: A Review. Critical Reviews in Analytical Chemistry 52:8, pages 1938-1968.
Read now
A. Salomone & J. J. Palamar. (2021) Toxicosurveillance of novel opioids: just screening tests may not be enough. The American Journal of Drug and Alcohol Abuse 47:3, pages 271-272.
Read now
Neeraj Chhabra, Lum Rizvanolli, Arkady Rasin, Granger Marsden, Keiki Hinami & Steven E Aks. (2021) A cross-sectional analysis of fentanyl analog exposures among living patients. The American Journal of Drug and Alcohol Abuse 47:3, pages 344-349.
Read now
Xander M. R. Van Wijk, Robert Goodnough & Jennifer M. Colby. (2019) Mass spectrometry in emergency toxicology: Current state and future applications. Critical Reviews in Clinical Laboratory Sciences 56:4, pages 225-238.
Read now
Inês Tabarra, Sofia Soares, Tiago Rosado, Joana Gonçalves, Ângelo Luís, Sara Malaca, Mário Barroso, Thomas Keller, José Restolho & Eugenia Gallardo. (2019) Novel synthetic opioids – toxicological aspects and analysis. Forensic Sciences Research 4:2, pages 111-140.
Read now
Olaf H. Drummer. (2019) Fatalities caused by novel opioids: a review. Forensic Sciences Research 4:2, pages 95-110.
Read now
Anders Helander, Matilda Bäckberg, Patrick Signell & Olof Beck. (2017) Intoxications involving acrylfentanyl and other novel designer fentanyls – results from the Swedish STRIDA project. Clinical Toxicology 55:6, pages 589-599.
Read now
Anders Helander & Matilda Bäckberg. (2017) New Psychoactive Substances (NPS) – the Hydra monster of recreational drugs. Clinical Toxicology 55:1, pages 1-3.
Read now
Aaron Schneir, Imir G. Metushi, Christian Sloane, David J. Benaron & Robert L. Fitzgerald. (2017) Near death from a novel synthetic opioid labeled U-47700: emergence of a new opioid class. Clinical Toxicology 55:1, pages 51-54.
Read now
Matilda Bäckberg, Jenny Westerbergh, Olof Beck & Anders Helander. (2016) Adverse events related to the new psychoactive substance 3-fluorophenmetrazine – results from the Swedish STRIDA project. Clinical Toxicology 54:9, pages 819-825.
Read now
Derrick Lung, Nathan Wilson, Francois-Thibaut Chatenet, Clemence LaCroix & Roy Gerona. (2016) Non-targeted screening for novel psychoactive substances among agitated emergency department patients. Clinical Toxicology 54:4, pages 319-323.
Read now
Matilda Bäckberg, Olof Beck & Anders Helander. (2015) Phencyclidine analog use in Sweden—intoxication cases involving 3-MeO-PCP and 4-MeO-PCP from the STRIDA project. Clinical Toxicology 53:9, pages 856-864.
Read now

Articles from other publishers (77)

Yoshio Nakagawa, Jin Suzuki, Toshinari Suzuki, Hideyo Takahashi, Kosho Makino, Yasushi Ono, Miho Sakamoto & Akiko Inomata. (2023) Cytotoxic effects of psychoactive isobutyrylfentanyl and its halogenated derivatives on isolated rat hepatocytes. Journal of Applied Toxicology 43:9, pages 1379-1392.
Crossref
Michelle Jin Yee Neoh, Alessandro Carollo, Mengyu Lim, Ornella Corazza, Aurora Coppola & Gianluca Esposito. (2023) The novel psychoactive substances epidemic: A scientometric perspective. Addiction Neuroscience 5, pages 100060.
Crossref
Maja Bergerhoff & Bjoern Moosmann. (2023) Novel Receptor-Binding-Based Assay for the Detection of Opioids in Human Urine Samples. Analytical Chemistry 95:5, pages 2723-2731.
Crossref
Ewelina Pieprzyca, Rafał Skowronek & Piotr Czekaj. (2022) Toxicological Analysis of Cases of Mixed Poisonings with Synthetic Cathinones and Other Drugs of Abuse. Journal of Analytical Toxicology 46:9, pages 1008-1015.
Crossref
Luke N. Rodda. 2023. Methods for Novel Psychoactive Substance Analysis. Methods for Novel Psychoactive Substance Analysis 73 91 .
Yu Zhang, John C. Halifax, Christina Tangsombatvisit, Cassandra Yun, Shaokun Pang, Shirin Hooshfar, Alan H.B. Wu & Kara L. Lynch. (2022) Development and application of a High-Resolution mass spectrometry method for the detection of fentanyl analogs in urine and serum. Journal of Mass Spectrometry and Advances in the Clinical Lab 26, pages 1-6.
Crossref
Katherine Smart, Karen Reyes, Kylie Wilder, William E. Acree Jr, Guido F. Verbeck & Teresa D. Golden. (2022) Ionic liquids as stationary phases for the gas chromatographic separation of fentanyl analogues. Forensic Chemistry, pages 100452.
Crossref
Qi Wei & Fu Hai Su. (2022) Determination of Nine Fentanyl Drugs in Hair Samples by GC-MS/MS and LC-MS/MS. ACS Omega 7:23, pages 19176-19182.
Crossref
Ana Y. Simão, Mónica Antunes, Emanuel Cabral, Patrik Oliveira, Luana M. Rosendo, Ana Teresa Brinca, Estefânia Alves, Hernâni Marques, Tiago Rosado, Luís A. Passarinha, Maristela Andraus, Mário Barroso & Eugenia Gallardo. (2022) An Update on the Implications of New Psychoactive Substances in Public Health. International Journal of Environmental Research and Public Health 19:8, pages 4869.
Crossref
Deborah Dal Farra, Alice Valdesalici, Giancarlo Zecchinato, Alfio De Sandre, Diego Saccon, Pierluigi Simonato, Ornella Corazza, Giovanni Martinotti, Andrew L. Smith & Marco Solmi. (2022) Knowledge and Use of Novel Psychoactive Substances in an Italian Sample with Substance Use Disorders. International Journal of Environmental Research and Public Health 19:2, pages 915.
Crossref
John R.H. Archer. 2022. Novel Psychoactive Substances. Novel Psychoactive Substances 131 156 .
Piotr Adamowicz & Karolina Nowak. (2021) Blood concentrations of new synthetic opioids. International Journal of Legal Medicine 136:1, pages 107-122.
Crossref
Krishna Tulasi Kirla, Claudia Erhart, Ksenia J. Groh, Julita Stadnicka-Michalak, Rik I.L. Eggen, Kristin Schirmer & Thomas Kraemer. (2021) Zebrafish early life stages as alternative model to study ‘designer drugs’: Concordance with mammals in response to opioids. Toxicology and Applied Pharmacology 419, pages 115483.
Crossref
Nicolas Gilbert, Ryan E. Mewis & Oliver B. Sutcliffe. (2021) Fast & fluorinated – Development and validation of a rapid benchtop NMR approach and other routine screening methods for the detection and quantification of synthesized fluorofentanyl derivatives. Forensic Chemistry 23, pages 100321.
Crossref
Marta Siczek, Marcin Zawadzki, Miłosz Siczek, Agnieszka Chłopaś-Konowałek & Paweł Szpot. (2020) Etazene (N,N-diethyl-2-{[(4-ethoxyphenyl)methyl]-1H-benzimidazol-1-yl}-ethan-1-amine (dihydrochloride)): a novel benzimidazole opioid NPS identified in seized material: crystal structure and spectroscopic characterization. Forensic Toxicology 39:1, pages 146-155.
Crossref
Máté Kapitány-Fövény, Ornella Corazza, Shanna Marrinan & Zsolt Demetrovics. 2020. The Cambridge Handbook of Substance and Behavioral Addictions. The Cambridge Handbook of Substance and Behavioral Addictions 307 325 .
. 2020. The Cambridge Handbook of Substance and Behavioral Addictions. The Cambridge Handbook of Substance and Behavioral Addictions 295 425 .
. 2020. The Cambridge Handbook of Substance and Behavioral Addictions. The Cambridge Handbook of Substance and Behavioral Addictions.
Kelly Francisco da Cunha, Leonardo Costalonga Rodrigues, Marilyn A. Huestis & Jose Luiz Costa. (2020) Miniaturized extraction method for analysis of synthetic opioids in urine by microextraction with packed sorbent and liquid chromatography—tandem mass spectrometry. Journal of Chromatography A 1624, pages 461241.
Crossref
Per Ole M. Gundersen, Sebastian Broecker, Lars Slørdal, Olav Spigset & Martin Josefsson. (2020) Retrospective screening of synthetic cannabinoids, synthetic opioids and designer benzodiazepines in data files from forensic post mortem samples analysed by UHPLC-QTOF-MS from 2014 to 2018. Forensic Science International 311, pages 110274.
Crossref
Anders Helander, Matilda Bäckberg & Olof Beck. (2020) Drug trends and harm related to new psychoactive substances (NPS) in Sweden from 2010 to 2016: Experiences from the STRIDA project. PLOS ONE 15:4, pages e0232038.
Crossref
Dino Luethi & Matthias E. Liechti. (2020) Designer drugs: mechanism of action and adverse effects. Archives of Toxicology 94:4, pages 1085-1133.
Crossref
Maurice Wilde, Michaela J. Sommer, Volker Auwärter & Maren Hermanns-Clausen. (2020) Acute severe intoxication with cyclopropylfentanyl, a novel synthetic opioid. Toxicology Letters 320, pages 109-112.
Crossref
María del Mar Ramírez Fernández, Sarah M.R. Wille, Danielle Jankowski, Virginia Hill & Nele Samyn. (2020) Development of an UPLC–MS/MS method for the analysis of 16 synthetic opioids in segmented hair, and evaluation of the polydrug history in fentanyl analogue users. Forensic Science International 307, pages 110137.
Crossref
Camille Richeval, Marie Baillieux, Geoffrey Pawlak, Mélodie Phanithavong, Jean-françois Wiart, Luc Humbert, Anne Batisse, Catherine Lamoureux, Grégory Pfau, Thomas Nefau, Delphine Allorge & Jean-Michel Gaulier. (2019) Benzoylfentanyl and parafluorobutyrfentanyl: Some analytical and metabolism data. Toxicologie Analytique et Clinique 31:4, pages 258-267.
Crossref
Alexander Dinh Le & Saeed Khaled Alzghari. (2019) Systematic review of the clinical consequences of butyrfentanyl and corresponding analogues. Interdisciplinary Toxicology 12:2, pages 83-88.
Crossref
Marianne Skov-Skov BerghInger Lise BogenAriane WohlfarthSteven Ray WilsonÅse Marit Leere Øiestad. (2019) Distinguishing Between Cyclopropylfentanyl and Crotonylfentanyl by Methods Commonly Available in the Forensic Laboratory. Therapeutic Drug Monitoring 41:4, pages 519-527.
Crossref
Edmund Rab, Robert J. Flanagan & Simon Hudson. (2019) Detection of fentanyl and fentanyl analogues in biological samples using liquid chromatography–high resolution mass spectrometry. Forensic Science International 300, pages 13-18.
Crossref
Neil B. Varshneya, D. Matthew Walentiny, Lea T. Moisa, Teneille D. Walker, Luli R. Akinfiresoye & Patrick M. Beardsley. (2019) Opioid-like antinociceptive and locomotor effects of emerging fentanyl-related substances. Neuropharmacology 151, pages 171-179.
Crossref
Kaitlyn B. Palmquist & Madeleine J. Swortwood. (2019) Data-independent screening method for 14 fentanyl analogs in whole blood and oral fluid using LC-QTOF-MS. Forensic Science International 297, pages 189-197.
Crossref
Béatrice Garneau, Brigitte Desharnais, Audrey Beauchamp-Doré, Catherine Lavallée, Pascal Mireault & André Lajeunesse. (2019) Challenges Related to Three Cases of Fatal Intoxication to Multiple Novel Synthetic Opioids. Journal of Analytical Toxicology.
Crossref
Paul J Jannetto, Anders Helander, Uttam Garg, Gregory C Janis, Bruce Goldberger & Hemamalini Ketha. (2019) The Fentanyl Epidemic and Evolution of Fentanyl Analogs in the United States and the European Union. Clinical Chemistry 65:2, pages 242-253.
Crossref
Barbara Lovrecic, Mercedes Lovrecic, Branko Gabrovec, Marco Carli, Matteo Pacini, Angelo G. I. Maremmani & Icro Maremmani. (2019) Non-Medical Use of Novel Synthetic Opioids: A New Challenge to Public Health. International Journal of Environmental Research and Public Health 16:2, pages 177.
Crossref
Tatsuyuki Kanamori, Yuko T. Iwata, Hiroki Segawa, Tadashi Yamamuro, Kenji Kuwayama, Kenji Tsujikawa & Hiroyuki Inoue. (2019) Characterization and differentiation of positional isomers of fluoro-fentanyl analogs by a combination of instrumental analyses各種機器分析によるフルオロ-フェンタニル類の位置異性体識別. Japanese Journal of Forensic Science and Technology 24:2, pages 123-133.
Crossref
Nektaria Misailidi, Sotiris Athanaselis, Panagiota Nikolaou, Maria Katselou, Yannis Dotsikas, Chara Spiliopoulou & Ioannis Papoutsis. (2018) A GC–MS method for the determination of furanylfentanyl and ocfentanil in whole blood with full validation. Forensic Toxicology 37:1, pages 238-244.
Crossref
Jessica Welter‐Luedeke & Hans H. Maurer. (2018) Relevance of published blood concentrations of new psychoactive substance for rational case interpretation. WIREs Forensic Science 1:1.
Crossref
Sara Casati, Mauro Minoli, Ilaria Angeli, Alessandro Ravelli, Graziano Domenico Luigi Crudele & Marica Orioli. (2019) An ocfentanil-related death case: UHPLC-MS/MS analysis of the drug. Drug Testing and Analysis 11:1, pages 173-177.
Crossref
Marianne Skov-Skov Bergh, Inger Lise BogenSteven Ray Wilson & Åse Marit Leere Øiestad. (2018) Addressing the Fentanyl Analogue Epidemic by Multiplex UHPLC-MS/MS Analysis of Whole Blood. Therapeutic Drug Monitoring 40:6, pages 738-748.
Crossref
Joseph H Kahl, Jennifer Gonyea, Susan M Humphrey, George W Hime & Diane M Boland. (2018) Quantitative Analysis of Fentanyl and Six Fentanyl Analogs in Postmortem Specimens by UHPLC–MS-MS†. Journal of Analytical Toxicology 42:8, pages 570-580.
Crossref
Anders Helander, Katarina Stojanovic, Tomas Villén & Olof Beck. (2018) Detectability of fentanyl and designer fentanyls in urine by 3 commercial fentanyl immunoassays. Drug Testing and Analysis 10:8, pages 1297-1304.
Crossref
Renata Solimini, Simona Pichini, Roberta Pacifici, Francesco P. Busardò & Raffaele Giorgetti. (2018) Pharmacotoxicology of Non-fentanyl Derived New Synthetic Opioids. Frontiers in Pharmacology 9.
Crossref
Emilia Marchei, Roberta Pacifici, Giulio Mannocchi, Enrico Marinelli, Francesco Paolo Busardò & Simona Pichini. (2018) New synthetic opioids in biological and non-biological matrices: A review of current analytical methods. TrAC Trends in Analytical Chemistry 102, pages 1-15.
Crossref
Patil Armenian, Kathy T. Vo, Jill Barr-Walker & Kara L. Lynch. (2018) Fentanyl, fentanyl analogs and novel synthetic opioids: A comprehensive review. Neuropharmacology 134, pages 121-132.
Crossref
Cuimei Liu, Tao Li, Yu Han, Zhendong Hua, Wei Jia & Zhenhua Qian. (2017) The identification and analytical characterization of 2,2′‐difluorofentanyl. Drug Testing and Analysis 10:4, pages 774-780.
Crossref
Carolina Noble, Petur Weihe Dalsgaard, Sys Stybe Johansen & Kristian Linnet. (2017) Application of a screening method for fentanyl and its analogues using UHPLC‐QTOF‐MS with data‐independent acquisition (DIA) in MS E mode and retrospective analysis of authentic forensic blood samples . Drug Testing and Analysis 10:4, pages 651-662.
Crossref
Simona Pichini, Renata Solimini, Paolo Berretta, Roberta Pacifici & Francesco Paolo Busardò. (2018) Acute Intoxications and Fatalities From Illicit Fentanyl and Analogues: An Update. Therapeutic Drug Monitoring 40:1, pages 38-51.
Crossref
Matilda Bäckberg, Karl-Henrik Jönsson, Olof Beck & Anders Helander. (2018) Investigation of drug products received for analysis in the Swedish STRIDA project on new psychoactive substances. Drug Testing and Analysis 10:2, pages 340-349.
Crossref
Jessica B. Dwyer, Jennifer Janssen, Todd M. Luckasevic & Karl E. Williams. (2018) Report of Increasing Overdose Deaths that include Acetyl Fentanyl in Multiple Counties of the Southwestern Region of the Commonwealth of Pennsylvania in 2015-2016. Journal of Forensic Sciences 63:1, pages 195-200.
Crossref
Achim T. Caspar, Andreas B. Kollas, Hans H. Maurer & Markus R. Meyer. (2018) Development of a quantitative approach in blood plasma for low-dosed hallucinogens and opioids using LC-high resolution mass spectrometry. Talanta 176, pages 635-645.
Crossref
Laura Hikin, Paul R. Smith, Eleanor Ringland, Simon Hudson & Stephen R. Morley. (2018) Multiple fatalities in the North of England associated with synthetic fentanyl analogue exposure: Detection and quantitation a case series from early 2017. Forensic Science International 282, pages 179-183.
Crossref
Simon L. Hill & Paul I. Dargan. 2018. New Psychoactive Substances. New Psychoactive Substances 475 494 .
Anders Helander & Matilda Bäckberg. 2018. New Psychoactive Substances. New Psychoactive Substances 461 473 .
Lea Wagmann & Hans H. Maurer. 2018. New Psychoactive Substances. New Psychoactive Substances 413 439 .
Barry K. Logan, Amanda L.A. Mohr, Melissa Friscia, Alex J. Krotulski, Donna M. Papsun, Sherri L. Kacinko, Jeri D. Ropero-Miller & Marilyn A. Huestis. (2017) Reports of Adverse Events Associated with Use of Novel Psychoactive Substances, 2013–2016: A Review. Journal of Analytical Toxicology 41:7, pages 573-610.
Crossref
Shimpei Watanabe, Svante Vikingsson, Markus Roman, Henrik Green, Robert Kronstrand & Ariane Wohlfarth. (2017) In Vitro and In Vivo Metabolite Identification Studies for the New Synthetic Opioids Acetylfentanyl, Acrylfentanyl, Furanylfentanyl, and 4-Fluoro-Isobutyrylfentanyl. The AAPS Journal 19:4, pages 1102-1122.
Crossref
Joshua Seither & Lisa Reidy. (2017) Confirmation of Carfentanil, U-47700 and Other Synthetic Opioids in a Human Performance Case by LC–MS-MS. Journal of Analytical Toxicology 41:6, pages 493-497.
Crossref
Dina M. Swanson, Laura S. Hair, Selly R. Strauch Rivers, Brianna C. Smyth, Sara C. Brogan, Alexis D. Ventoso, Samantha L. Vaccaro & Julia M. Pearson. (2017) Fatalities Involving Carfentanil and Furanyl Fentanyl: Two Case Reports. Journal of Analytical Toxicology 41:6, pages 498-502.
Crossref
István Ujváry, Rita Jorge, Rachel Christie, Thomas Le Ruez, Helgi Valur Danielsson, Robert Kronstrand, Simon Elliott, Ana Gallegos, Roumen Sedefov & Michael Evans-Brown. (2017) Acryloylfentanyl, a recently emerged new psychoactive substance: a comprehensive review. Forensic Toxicology 35:2, pages 232-243.
Crossref
Andrea E. Steuer, Elena Williner, Sandra N. Staeheli & Thomas Kraemer. (2017) Studies on the metabolism of the fentanyl-derived designer drug butyrfentanyl in human in vitro liver preparations and authentic human samples using liquid chromatography-high resolution mass spectrometry (LC-HRMS). Drug Testing and Analysis 9:7, pages 1085-1092.
Crossref
Melissa M. Goggin, An Nguyen & Gregory C. Janis. (2017) Identification of Unique Metabolites of the Designer Opioid Furanyl Fentanyl. Journal of Analytical Toxicology 41:5, pages 367-375.
Crossref
Anders Helander. 2017. Detection of Drug Misuse: Biomarkers, Analytical Advances and Interpretation. Detection of Drug Misuse: Biomarkers, Analytical Advances and Interpretation 83 99 .
A. Helander, M. Bradley, A. Hasselblad, L. Norlén, I. Vassilaki, M. Bäckberg & J. Lapins. (2017) Acute skin and hair symptoms followed by severe, delayed eye complications in subjects using the synthetic opioid MT-45. British Journal of Dermatology 176:4, pages 1021-1027.
Crossref
Marcin Rojkiewicz, Milena Majchrzak, Rafał Celiński, Piotr Kuś & Mieczysław Sajewicz. (2017) Identification and physicochemical characterization of 4-fluorobutyrfentanyl (1-((4-fluorophenyl)(1-phenethylpiperidin-4-yl)amino)butan-1-one, 4-FBF) in seized materials and post-mortem biological samples. Drug Testing and Analysis 9:3, pages 405-414.
Crossref
Torben Breindahl, Andreas Kimergård, Mette Findal Andreasen & Daniel Sejer Pedersen. (2017) Identification of a new psychoactive substance in seized material: the synthetic opioid N -phenyl- N -[1-(2-phenethyl)piperidin-4-yl]prop-2-enamide (Acrylfentanyl) . Drug Testing and Analysis 9:3, pages 415-422.
Crossref
Pol Quintana, Mireia Ventura, Marc Grifell, Alvaro Palma, Liliana Galindo, Iván Fornís, Cristina Gil, Xoán Carbón, Fernando Caudevilla, Magí Farré & Marta Torrens. (2017) The hidden web and the fentanyl problem: Detection of ocfentanil as an adulterant in heroin. International Journal of Drug Policy 40, pages 78-83.
Crossref
Davide Guerrieri, Emma Rapp, Markus Roman, Henrik Druid & Robert Kronstrand. (2017) Postmortem and Toxicological Findings in a Series of Furanylfentanyl-Related Deaths. Journal of Analytical Toxicology.
Crossref
Scott N. Lucyk & Lewis S. Nelson. (2017) Novel Synthetic Opioids: An Opioid Epidemic Within an Opioid Epidemic. Annals of Emergency Medicine 69:1, pages 91-93.
Crossref
Hannah R. Fudin, Jennifer L. Babin, Alisyn L. Hansen & Sidhartha D. Ray. 2017. A Worldwide Yearly Survey of New Data in Adverse Drug Reactions. A Worldwide Yearly Survey of New Data in Adverse Drug Reactions 31 55 .
Chris Kostakis, Peter Harpas & Peter C. Stockham. 2017. Liquid Chromatography. Liquid Chromatography 301 358 .
Justin Poklis, Alphonse Poklis, Carl Wolf, Cindie Hathaway, Elise Arbefeville, Leszek Chrostowski, Kelly Devers, Laura Hair, Mary Mainland, Michele Merves & Julia Pearson. (2016) Two Fatal Intoxications Involving Butyryl Fentanyl. Journal of Analytical Toxicology 40:8, pages 703-708.
Crossref
Markus R. Meyer. (2016) New psychoactive substances: an overview on recent publications on their toxicodynamics and toxicokinetics. Archives of Toxicology 90:10, pages 2421-2444.
Crossref
Sandra N. Staeheli, Markus R. Baumgartner, Saskia Gauthier, Dominic Gascho, Juliane Jarmer, Thomas Kraemer & Andrea E. Steuer. (2016) Time-dependent postmortem redistribution of butyrfentanyl and its metabolites in blood and alternative matrices in a case of butyrfentanyl intoxication. Forensic Science International 266, pages 170-177.
Crossref
Markus R. Meyer & Hans H. Maurer. (2016) Review: LC coupled to low- and high-resolution mass spectrometry for new psychoactive substance screening in biological matrices – Where do we stand today?. Analytica Chimica Acta 927, pages 13-20.
Crossref
Markus R. Meyer, Madeleine Pettersson Bergstrand, Anders Helander & Olof Beck. (2016) Identification of main human urinary metabolites of the designer nitrobenzodiazepines clonazolam, meclonazepam, and nifoxipam by nano-liquid chromatography-high-resolution mass spectrometry for drug testing purposes. Analytical and Bioanalytical Chemistry 408:13, pages 3571-3591.
Crossref
Iain M. McIntyre, Amber Trochta, Ray D. Gary, Jennifer Wright & Othon Mena. (2016) An Acute Butyr-Fentanyl Fatality: A Case Report with Postmortem Concentrations. Journal of Analytical Toxicology 40:2, pages 162-166.
Crossref
Hege M. Krabseth, Silja S. Tuv, Maren Cecilie Strand, Ritva A. Karinen, Elisabeth Wiik, Merete S. Vevelstad, Andreas Austgulen Westin, Elisabeth L. Øiestad & Vigdis Vindenes. (2016) Nye psykoaktive stoffer. Tidsskrift for Den norske legeforening 136:8, pages 714-717.
Crossref
. (2016) Clonazepam/pregabalin. Reactions Weekly 1583:1, pages 323-323.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.